Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Ngwa W, Olver I, Schmeler KM. The use of health-related technology to reduce the gap between developed and undeveloped regions around the Globe. Am Soc Clin Oncol Educ Book. 2020;40:1–10.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.
Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global Cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev. 2017;26(4):444–57.
Rerucha CM, Caro RJ, Wheeler VL. Cervical Cancer screening. Am Fam Physician. 2018;97(7):441–8.
Tergas AI, Wright JD. Cancer prevention strategies for women. Obstet Gynecol. 2019;134(1):30–43.
Gupta R, Gupta S, Mehrotra R, Sodhani P. Cervical Cancer screening in resource-constrained countries: current status and future directions. Asian Pac J Cancer Prev. 2017;18(6):1461–7.
Qiao L, Li B, Long M, Wang X, Wang A, Zhang G. Accuracy of visual inspection with acetic acid and with Lugol’s iodine for cervical cancer screening: Meta-analysis. J Obstet Gynaecol Res. 2015;41(9):1313–25.
da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clin (Sao Paulo). 2017;72(4):244–53.
Ngan TT, Nguyen NTQ, Van Minh H, Donnelly M, O’Neill C. Effectiveness of clinical breast examination as a ‘stand-alone’ screening modality: an overview of systematic reviews. BMC Cancer. 2020;20(1):1070.
Albert US, Schulz KD. Clinical breast examination: what can be recommended for its use to detect breast cancer in countries with limited resources? Breast J. 2003;9(Suppl 2):90–3.
Eddy DM. Screening for breast cancer. Ann Intern Med. 1989;111(5):389–99.
Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA. 1999;282(13):1270–80.
University of Indonesia Strategic Studies Grant Recipient Team. Five Pillar Model in the implementation of Cervical Cancer Prevention Programs. Tim Penerima Hibah Kajian Strategis Universitas Indonesia. editor. Jakarta: UI Publishing; 2018.
Denny L, Quinn M, Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine. 2006;24(Suppl 3):3/71–7.
Nessa A, Ara R, Fatema P, Nasrin B, Chowdhury A, Khan KH, et al. Influence of demographic and Reproductive factors on cervical pre-cancer and Cancer in Bangladesh. Asian Pac J Cancer Prev. 2020;21(7):1883–9.
Ploysawang P, Rojanamatin J, Prapakorn S, Jamsri P, Pangmuang P, Seeda K, et al. National cervical Cancer screening in Thailand. Asian Pac J Cancer Prev. 2021;22(1):25–30.
Adsul P, Manjunath N, Srinivas V, Arun A, Madhivanan P. Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: a systematic review. Cancer Epidemiol. 2017;49:161–74.
Hu SY, Zhao XL, Zhao FH, Wei LH, Zhou Q, Niyazi M, et al. Implementation of visual inspection with acetic acid and Lugol’s iodine for cervical cancer screening in rural China. Int J Gynaecol Obstet. 2022;1–8. https://doi.org/10.1002/ijgo.14368.
Newman LA. Breast cancer screening in low and middle-income countries. Best Pract Res Clin Obstet Gynaecol. 2022;83:15–23.
WHO. Indonesia (Source: Globocan 2020). 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf. Cited 2021 June 21.
Nuranna L, Donny NB, Purwoto G, Winarto H, Utami TW, Anggraeni TD, et al. Prevalence, age distribution, and risk factors of Visual Inspection with acetic acid-positive from 2007 to 2011 in Jakarta. J Cancer Prev. 2017;22(2):103–7.
Nuranna L, Aziz MF, Cornain S, Purwoto G, Purbadi S, Budiningsih S, et al. Cervical cancer prevention program in Jakarta, Indonesia: see and treat model in developing country. J Gynecol Oncol. 2012;23(3):147–52.
Kardinah D, Anderson BO, Duggan C, Ali IA, Thomas DB. Short report: limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia. Int J Cancer. 2014;134(5):1250–5.
Sirait LM, Anggreni LA, Pradibta CA, Widyastuti W, Prasetyo WE, Puspitasari HD, et al. Prevalence and factors associated with visual inspection of the cervix after acetic acid application positive result among female civil servants and wives of civil servants in Jakarta. Future Healthc J. 2019;6(Suppl 1):82.
Wahidin M, Febrianti R, Susanty F, Hasanah SR. Twelve years implementation of cervical and breast Cancer screening program in Indonesia. Asian Pac J Cancer Prev. 2022;23(3):829–37.
Veitch D, Goossens R, Owen H, Veitch J, Molenbroek J, Bochner M. Evaluation of conventional training in clinical breast examination (CBE). Work. 2019;62(4):647–56.
Batubara JR, Soesanti F, van de Waal HD. Age at menarche in indonesian girls: a national survey. Acta Med Indones. 2010;42(2):78–81.
WHO. Guidelines on physical activity and sedentary Behaviour. Geneva: WHO; 2020.
Bray F, Soerjomataram I. The Changing Global Burden of Cancer: Transitions in Human Development and Implications for Cancer Prevention and Control. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): World Bank; 2015.
Coughlin SS. Epidemiology of breast Cancer in women. Adv Exp Med Biol. 2019;1152:9–29.
Tamimi RM, Spiegelman D, Smith-Warner SA, Wang M, Pazaris M, Willett WC, et al. Population attributable risk of modifiable and nonmodifiable breast Cancer risk factors in postmenopausal breast Cancer. Am J Epidemiol. 2016;184(12):884–93.
McCormack VA, Boffetta P. Today’s lifestyles, tomorrow’s cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol. 2011;22(11):2349–57.
Dalton M, Holzman E, Erwin E, Michelen S, Rositch AF, Kumar S, et al. Patient navigation services for cancer care in low-and middle-income countries: a scoping review. PLoS ONE. 2019;14(10):e0223537.
Freeman HP, Rodriguez RL. History and principles of patient navigation. Cancer. 2011;117(15 Suppl):3539–42.
Dare AJ, Knapp GC, Romanoff A, Olasehinde O, Famurewa OC, Komolafe AO, et al. High-burden cancers in Middle-income countries: a review of Prevention and early detection strategies targeting At-risk populations. Cancer Prev Res (Phila). 2021;14(12):1061–74.
Lertcharernrit J, Sananpanichkul P, Suknikhom W, Bhamarapravatana K, Suwannarurk K, Leaungsomnapa Y. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic acid for pregnant women at a thai Provincial Hospital. Asian Pac J Cancer Prev. 2016;17(8):4163–7.
Zhang Q, Xie W, Wang F, Li RH, Cui L, Wang H, et al. Epidemiological investigation and risk factors for cervical lesions: cervical Cancer screening among women in rural Areas of Henan Province China. Med Sci Monit. 2016;22:1858–65.
Vidhubala E, Shewade HD, Niraimathi AK, Ramkumar S, Ramaswamy G, Nagalekshmi G, et al. Call for systematic Population-Based cervical Cancer screening: findings from Community-Based screening camps in Tamil Nadu, India. Asian Pac J Cancer Prev. 2019;20(12):3703–10.
Dhakal R, Noula M, Roupa Z, Yamasaki EN. A scoping review on the Status of female breast Cancer in Asia with a special focus on Nepal. Breast Cancer (Dove Med Press). 2022;14:229–46.
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
Bekos C, Schwameis R, Heinze G, Garner M, Grimm C, Joura E, et al. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis. Sci Rep. 2018;8(1):6383.
Solikhah S, Lianawati L, Matahari R, Rejeki DSS. Determinants of breast Cancer screening practice among women in Indonesia: a Nationwide Study. Asian Pac J Cancer Prev. 2021;22(5):1435–41.
Islam RM, Billah B, Hossain MN, Oldroyd J. Barriers to cervical Cancer and breast Cancer screening uptake in low-income and middle-income Countries: a systematic review. Asian Pac J Cancer Prev. 2017;18(7):1751–63.
Pfeiffer RM, Webb-Vargas Y, Wheeler W, Gail MH. Proportion of U.S. Trends in breast Cancer incidence attributable to long-term changes in risk factor distributions. Cancer Epidemiol Biomarkers Prev. 2018;27(10):1214–22.
Karadag Arli S, Bakan AB, Aslan G. Distribution of cervical and breast cancer risk factors in women and their screening behaviours. Eur J Cancer Care (Engl). 2019;28(2):e12960.